Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

46.32
Delayed Data
As of Jun 23
 +0.95 / +2.09%
Today’s Change
38.80
Today|||52-Week Range
85.83
-7.03%
Year-to-Date

Today’s Trading

Previous close45.37
Today’s open45.35
Day’s range45.16 - 46.43
Volume3,115,739
Average volume (3 months)2,117,585
Market cap$4.6B
Dividend yield--
Data as of 4:01pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+78.72%
Earnings growth (this year)--
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+1.01%
P/E ratio25.3
Price/Sales2.30
Price/Book0.94

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc-1.78-1.84%
CTLTCatalent Inc-0.58-1.53%
TAROTaro Pharmaceutical ...+2.04+1.79%
AGNPRAAllergan plc-2.56-0.29%
Data as of 4:05pm ET, 06/23/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$1.73
Annual revenue (last year)$3.4B
Annual profit (last year)$548.0M
Net profit margin14.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Chesterfield, Derbyshire

Forecasts